Can you mix BPC-157 and TB-500 in the same syringe?
The BPC-157 + TB-500 stack is the most common soft-tissue healing pairing in research peptide use. Running them on the same day inevitably raises the question — can we skip the second injection and combine?
Why this question exists
BPC-157 is typically dosed daily at ~250–500 mcg subcutaneously. TB-500 is most often dosed as a 2–10 mg loading phase over several weeks, split into daily or every-other-day injections. Schedules overlap. Two small-volume SC injections per day feels like friction — one is easier, better tolerated, and easier to track.
Compatibility in aqueous buffer
Both BPC-157 and TB-500 reconstitute cleanly in bacteriostatic water and are used in similar pH ranges (roughly neutral). They are both water-soluble peptides with no known direct chemical incompatibility reported in the research literature. When drawn into a single syringe immediately before injection, the two peptides share a buffer for a matter of seconds to minutes — not long enough for meaningful chemical interaction in either direction.
This is fundamentally different from pre-mixing for storage, which is not recommended. Short co-residency in a syringe: probably fine. Days in the same vial: introduces uncertainty about both concentrations and chemistry.
The one-syringe workflow
- Reconstitute each vial separately. BPC-157 in one vial, TB-500 in another. Record the concentration per your usual tracking.
- Use the reconstitution calculator for each. See BPC-157 and TB-500 variants. Know the exact unit marking for each dose before drawing.
- Draw BPC-157 first. To the unit mark for the BPC-157 dose.
- Draw TB-500 second. Without removing the syringe barrel's markings from view. Pull the plunger to the new mark that equals BPC-157 units + TB-500 units.
- Inspect the syringe. Clear. No wisps, particles, or cloudiness.
- Inject promptly. Within minutes. Do not save a loaded syringe for later.
When to keep them separate
Integrity doubts. If one vial looks cloudy, has been stored poorly, or you're uncertain it's the concentration you recorded — don't combine. Separate syringes let you catch a bad vial without losing the other dose. See our post on cloudy BPC-157.
Different buffer chemistry. If you're also adding a GLP-1 agonist (Semaglutide, Tirzepatide), an oil-suspended compound, or any product with a non-aqueous or non-neutral-pH vehicle, don't co-mix. Pharmaceutical compatibility requires formulation work, not an educated guess.
Different sites or timing. If the clinical reason for the stack is targeting different tissue areas (e.g. BPC-157 near an injury, TB-500 systemic), two separate injections at different sites may be deliberate.
Storage and documentation
Mixed syringes should be used within a few minutes of drawing. Don't refrigerate loaded syringes; don't leave them on the counter. Your tracking should still show two discrete doses — one injection is not one dose. If anything goes wrong, "BPC 250 mcg + TB-500 2000 mcg via SC thigh" is the record you want, not "combined healing stack injection."
FAQ
Is it safe to draw BPC-157 and TB-500 into the same syringe?
For subcutaneous research use, drawing both peptides from separate vials into one syringe immediately before injection is generally considered acceptable. Key disciplines: reconstitute each separately, draw in sequence, inject promptly, never store a pre-mixed syringe.
Should I pre-mix them in a single vial?
No. Pre-mixing introduces concentration uncertainty, accelerates chemical interactions, and makes dose adjustments difficult. Each peptide keeps its own vial and reconstitution record.
Does mixing change the effect of either peptide?
Effect is determined by dose and pharmacokinetics, not by whether the peptides shared a syringe. One-syringe injection saves a needle stick; it doesn't create pharmacologic synergy beyond running the two on the same schedule.
Can I mix BPC-157 with GLP-1s like Semaglutide in the same syringe?
Not without formulation expertise. GLP-1s have specific pH and buffer requirements, and they're typically dosed on a weekly cadence distinct from BPC-157. Keep separate syringes and ideally separate sessions.
What's the advantage of combining at all?
One injection instead of two, less site-irritation load, and a cleaner tracking record. The trade-off is that a problem with one vial compromises both doses in that session.
Related reading
Two peptides, one syringe, two log entries
Peptide Protocol logs each compound separately so your tracking stays clean even when your workflow condenses them.
Get the iPhone app →Informational and educational only. Not medical advice. Consult a licensed clinician before starting, changing, or stopping any peptide protocol. BPC-157 and TB-500 are not FDA-approved; references to research use reflect the published literature and common practice, not a medical recommendation.